Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

156 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024
Marinomed Biotech : Update Q1 2024
PU
Marinomed Biotech AG announces results for the first quarter of 2024
EQ
Transcript : MLP SE, Q1 2024 Earnings Call, May 15, 2024
Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQ
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
EQ
Marinomed Biotech AG announces preliminary revenue for 2023
EQ
Marinomed Biotech AG evaluates strategic options for Carragelose portfolio
EQ
Transcript : Marinomed Biotech AG, Nine Months 2023 Earnings Call, Nov 21, 2023
Marinomed Biotech AG: Stable revenues in the first three quarters of 2023 and further progress in business development
EQ
Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume
EQ
Transcript : Marinomed Biotech AG, H1 2023 Earnings Call, Aug 17, 2023
Marinomed Biotech AG reports record revenues in the first half of the year and pushes business development activities
EQ
Transcript : Marinomed Biotech AG, Q1 2023 Earnings Call, May 23, 2023
Marinomed Biotech AG reports best first quarter in company history
EQ
Transcript : Marinomed Biotech AG, 2022 Earnings Call, Apr 19, 2023
Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023
EQ
Pyrum Innovations AG: Chairman of the Supervisory Board increases his shareholding in the company
EQ
Marinomed Biotech AG announces preliminary revenue for 2022 with double-digit growth for Carragelose
EQ
WWF and Beiersdorf extend cooperation for more sustainable palm oil production in Indonesia until 2026
AQ
Marinomed Biotech AG: Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents
EQ
Marinomed Biotech : Investor Presentation Q3 2022
PU
Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 and significant business development progress
EQ
Marinomed Biotech : Conference Call Invitation Results Q3 2022
PU
Marinomed Biotech : Investor Presentation LSX Inv€$tival November 2022
PU
Transcript : Innergex Renewable Energy Inc. - Analyst/Investor Day
Marinomed Biotech : to attend several upcoming investor and industry conferences
PU
Marinomed to attend several upcoming investor and industry conferences
EQ
Marinomed Biotech : Investor Presentation H1 2022
PU
Marinomed Biotech : continues its growth path and reports strong financials in H1 2022
PU
Marinomed Biotech AG continues its growth path and reports strong financials in H1 2022
EQ
Marinomed Biotech : Conference Call Invitation - Half Year Results 2022
PU
Marinomed Biotech : to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green
PU
Marinomed to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green
EQ
Marinomed Biotech : Investor Presentation Equity Forum 2022
PU
Transcript : Daiichi Sankyo Company, Limited - Special Call
Marinomed Biotech : Resolution proposals of the management and the supervisory board 2021 (convenience translation)
PU
Marinomed Biotech : Investor Presentation Equity Forum
PU
Transcript : Marinomed Biotech AG, Q1 2022 Earnings Call, May 23, 2022
Marinomed Biotech : Investor Presentation Q1 2022
PU
Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose
EQ
Marinomed Biotech : Update Q1 2022
PU
Marinomed to attend several upcoming investor conferences
EQ
Transcript : Roche Holding AG - Special Call
Transcript : Marinomed Biotech AG, 2021 Earnings Call, Apr 13, 2022
Marinomed Biotech : Investor Presentation - Full Year Results 2021
PU
Marinomed reports on strong 2021 financial year
EQ
Marinomed Biotech : Conference Call Invitation - Full Year Results 2021
PU
Supervisory Board of Pyrum Innovations AG extends contract with CEO Pascal Klein and appoints Kai Winkelmann to the Executive Board
EQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Pascale Schmidt
  4. News